Phase III Study in Refractory Behcet's Disease

Novartis Investigative Site, Lausanne

Novartis Investigative Site, Bern

Novartis Investigative Site, Monastir

Novartis Investigative Site, Amman

Novartis Investigative Site, Afula

Novartis Investigative Site, Milan

Novartis Investigative Site, Nahariya

Novartis Investigative Site, Irbid

Novartis Investigative Site, Pátrai

Novartis Investigative Site, Lin-Ko

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Izmir

Novartis Investigative Site, Grenoble

Novartis Investigative Site, Larissa

Novartis Investigative Site, Essen

Novartis Investigative Site, Ioannina

Novartis Investigative Site, Münster

Novartis Investigative Site, Ramat Gan

Novartis Investigative Site, Ancona

Novartis Investigative Site, Tel Aviv

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Arlington

Novartis Investigative Site, Houston

Novartis Investigative Site, Singapore

Novartis Investigative Site, Chennai

Novartis Investigative Site, Madurai

Novartis Investigative Site, Angamaly

Novartis Investigative Site, Baltimore

Novartis Investigative Site, Alexandria

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Sfax

Novartis Investigative Site, Tunis

Novartis Investigative Site, Dessau

Novartis Investigative Site, Athens

Novartis Investigative Site, Larissa

Novartis Investigative Site, Athens

Novartis Investigative Site, Heraklion - Crete

Novartis Investigative Site, Ioannina

Novartis Investigative Site, New Delhi

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Ankara

Novartis Investigative Site, Ankara

Novartis Investigative Site, Altindag / Ankara